Gainers
- NanoVibronix NAOV stock increased by 23.8% to $2.86 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 65.6 million shares, making up 511.96% of its average full-day volume over the last 100 days. The company's market cap stands at $68.9 million.
- Xenetic Biosciences XBIO stock rose 20.82% to $3.91. As of 12:30 EST, this security is trading at a volume of 25.3 million shares, making up 276.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.9 million.
- Sesen Bio SESN stock increased by 18.93% to $4.8. Trading volume for this security as of 12:30 EST is 13.3 million, which is 205.83% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $941.7 million. The company's, Q2 earnings came out 3 days ago.
- Apyx Medical APYX shares increased by 17.1% to $10.75. The current volume of 90.3K shares is 113.83% of Apyx Medical's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $368.9 million. The company's, Q2 earnings came out today.
- OncoCyte OCX shares rose 13.75% to $4.63. The current volume of 7.4 million shares is 1615.24% of OncoCyte's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $423.4 million. As per the news, the Q2 earnings report came out 2 days ago.
- Liquidia LQDA stock rose 11.86% to $2.64. As of 12:30 EST, this security is trading at a volume of 370.5K shares, making up 98.19% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $137.2 million. As per the press release, Q2 earnings came out 2 days ago.
Losers
- VYNE Therapeutics VYNE stock declined by 29.02% to $2.05 during Thursday's regular session. The current volume of 3.3 million shares is 465.74% of VYNE Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $105.4 million. As per the news, the Q2 earnings report came out today.
- Revolution Medicines RVMD shares decreased by 12.59% to $23.52. As of 12:30 EST, Revolution Medicines's stock is trading at a volume of 1.5 million, which is 253.39% of its average full-day volume over the last 100 days. The company's market cap stands at $1.7 billion. As per the press release, Q2 earnings came out yesterday.
- Achilles Therapeutics ACHL shares declined by 11.37% to $5.85. Achilles Therapeutics's stock is trading at a volume of 402.6K shares as of 12:30 EST. This is 410.49% of its average full-day volume over the last 100 days. The company's market cap stands at $237.5 million. As per the press release, Q2 earnings came out 2 days ago.
- Trevena TRVN stock fell 11.08% to $1.25. As of 12:30 EST, Trevena's stock is trading at a volume of 3.9 million, which is 168.23% of its average full-day volume over the last 100 days. The company's market cap stands at $204.8 million. As per the news, the Q2 earnings report came out today.
- Generation Bio GBIO stock declined by 9.98% to $21.43. The current volume of 142.7K shares is 42.63% of Generation Bio's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $1.2 billion. As per the press release, Q2 earnings came out yesterday.
- Evofem Biosciences EVFM stock declined by 9.9% to $0.76. Trading volume for Evofem Biosciences's stock is 8.5 million as of 12:30 EST. This is 69.88% of its average full-day volume over the last 100 days. The company's market cap stands at $116.4 million. As per the press release, Q2 earnings came out yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in